MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Response of extraocular movements in parkinson’s disease to levodopa: an electrooculographic perspective

    S. Patel, C. Sankhla, R. Savaj (Mumbai, India)

    Objective: To determine the response of latencies and amplitudes of saccadic movements to Levodopa in idiopathic Parkinson’s Disease. Background: Neurodegeneration in Parkinson’s Disease (PD) increases…
  • 2023 International Congress

    Ventral tegmental deep brain stimulation does not influence risk-taking behaviour in a standard gambling task

    S. Hirschbichler, S. Lagrata, M. Matharu, S. Manohar (St. Pölten, Austria)

    Objective:  We here used a standard gambling task that involved risky decision-making. This permitted us to measure the effects of ventral tegmental area (VTA) deep…
  • 2023 International Congress

    Hemichorea syndrome secondary to diabetic striatopathy with contralateral drug-induced parkinsonism: a different threshold for drug induced movement disorders?

    C. Santoro, S. Landolfo, V. Velucci, G. Iliceto (Bari, Italy)

    Objective: Localized structural damages could impair the threshold of activation and/or inhibition of the nigrostriatal pathway with a mirrored effect on the healthy and pathological…
  • 2023 International Congress

    Effects of Unilateral and Bilateral DBS of STN, GPi on Voice in PD Patients

    M. Siddiqui, S. Naing, K. Ruckart, R. Hayes, L. Jafri, M. Moya-Mendez, L. Madden, J. Tate (Winston-Salem, USA)

    Objective: To study the effects of Deep Brain Stimulation (DBS) of subthalamic nucleus (STN) and globus pallidus interna (GPi) on voice in patients with Parkinson’s…
  • 2023 International Congress

    The High Prevalence of Developmental Vascular Anomalies in Parkinson’s Disease using USPIO-based MICRO MRI

    S. Sharma, S. Buch, D. Reese, T. Wade, G. Prado Miranda, M. Haacke, C. Tzoulis, M. Jog (London, Canada)

    Objective: To improve cerebral vascular visibility using an ultra-small super-paramagnetic iron oxide (USPIO) contrast agent and identify vascular abnormalities in patients with Parkinson’s disease (PD).…
  • 2023 International Congress

    How do people with Parkinson’s disease experience self-optimization of treatment using digitally supported symptom monitoring?

    K. Fåglum, A. Hjorth, M. Christani, P. Hagell, A. Ozanne, F. Bergquist (Varberg, Sweden)

    Objective: The aim of this study was to investigate how people with Parkinson´s disease experience an intervention of optimizing their own medical treatment through digitally…
  • 2023 International Congress

    Outcomes of patients treated with staged bilateral MRgHIFU thalamotomy using four-tract tractography targeting for medically refractory Essential Tremor

    N. Saez Calveras, D. Imphean, V. Sharma, L. Lanford, J. Viera, P. O'Suilleabhain, B. Shah (Dallas, USA)

    Objective: The goal of this study was to study the outcomes of 10 patients with medically refractory Essential Tremor (ET) treated with staged bilateral MR-guided…
  • 2023 International Congress

    Influence of Cognitive Function on Obstacle-Crossing Performance in People with Parkinson’s Disease: A Cross-Sectional Study

    HH. Hsu, RY. Wang, NC. Yeh, PL. Wong, CW. Hung (Taipei, Taiwan)

    Objective: This study investigated the influence of cognitive function on obstacle crossing performance in people with Parkinson's disease (PD). Background: Obstacle-crossing is a complex motor…
  • 2023 International Congress

    Blood derived α-synuclein seeding in the course of Parkinson’s Disease

    A. Kluge, E. Schaeffer, K. Brockmann, C. Schulte, C. Deuschle, J. Bunk, W. Maetzler, D. Berg (Kiel, Germany)

    Objective: To identify seeding capacities of soluble α-synuclein (α-syn) conformers derived from neuronal extracellular vesicles (NEs) from Parkinson´s disease (PD) patients with different disease durations…
  • 2023 International Congress

    Rasagiline in Chinese patients with early-stage parkinson’s disease: a randomized, double-blind, placebo-controlled, delayed-start trial

    W. Su, HJ. Liu, LJ. Wang, QY. Ye, L. Cao, HY. Zhou, XG. Luo, ZT. Ding, T. Wang, Q. Wang, HZ. Ma, EH. Xu, HB. Chen (Beijing, China)

    Objective: Objective: This randomized, double-blind, placebo-controlled, delayed-start trial aimed to investigate the efficacy in symptom improvement and disease-modifying effect of rasagiline for Chinese patients with…
  • « Previous Page
  • 1
  • …
  • 151
  • 152
  • 153
  • 154
  • 155
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley